OroselolCAS# 1891-25-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 1891-25-4 | SDF | Download SDF |
PubChem ID | 160600 | Appearance | Powder |
Formula | C14H12O4 | M.Wt | 244.2 |
Type of Compound | Coumarins | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 8-(2-hydroxypropan-2-yl)furo[2,3-h]chromen-2-one | ||
SMILES | CC(C)(C1=CC2=C(O1)C=CC3=C2OC(=O)C=C3)O | ||
Standard InChIKey | KDJVHSVOXOZBDR-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C14H12O4/c1-14(2,16)11-7-9-10(17-11)5-3-8-4-6-12(15)18-13(8)9/h3-7,16H,1-2H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Oroselol, jatamansinol, nardostachysin, jatamansinone and nardosinone are Nardostachys jatamansi rhizome extract marker compounds. |
Targets | VEGFR | CDK | Bcl-2/Bax | EGFR | NO |
In vitro | Strong Anti-tumorous Potential of Nardostachys jatamansi Rhizome Extract on Glioblastoma and In Silico Analysis of its Molecular Drug Targets.[Pubmed: 27774879]Curr Cancer Drug Targets. 2017;17(1):74-88.Glioblastoma has been reckoned as the prime cause of death due to brain tumours, being the most invasive and lethal. Available treatment options, i.e. surgery, radiotherapy, chemotherapy and targeted therapies are not effective in improving prognosis, so an alternate therapy is insistent. Plant based drugs are efficient due to their synergistic action, multi-targeted approach and least side effects.
Biotransformation of columbianadin by rat hepatic microsomes and inhibition of biotransformation products on NO production in RAW 264.7 cells in vitro.[Pubmed: 22784551 ]Phytochemistry. 2012 Sep;81:109-16.Columbianadin (CBN, 1), 1-[(8S)-8,9-dihydro-2-oxo-2H-furo[2,3-h]-1-benzopyran-8-yl]-1-methylethyl-[(2Z)-2-methyl-2-butenoic acid]ester is a coumarin-type compound and one of the main bioactive constituents of the underground part of Angelica pubescens Maxim. f. biserrata Shan et Yuan. |
Oroselol Dilution Calculator
Oroselol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.095 mL | 20.475 mL | 40.95 mL | 81.9001 mL | 102.3751 mL |
5 mM | 0.819 mL | 4.095 mL | 8.19 mL | 16.38 mL | 20.475 mL |
10 mM | 0.4095 mL | 2.0475 mL | 4.095 mL | 8.19 mL | 10.2375 mL |
50 mM | 0.0819 mL | 0.4095 mL | 0.819 mL | 1.638 mL | 2.0475 mL |
100 mM | 0.041 mL | 0.2048 mL | 0.4095 mL | 0.819 mL | 1.0238 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- [Ala92]-p16 (84-103)
Catalog No.:BCC5837
CAS No.:189064-08-2
- NGB 2904
Catalog No.:BCC7435
CAS No.:189061-11-8
- Corynantheine
Catalog No.:BCN3746
CAS No.:18904-54-6
- 1-(4-Hydroxy-2,2-dimethylchroman-6-yl)ethanone
Catalog No.:BCN7710
CAS No.:1890153-71-5
- Melilotigenin C
Catalog No.:BCN1165
CAS No.:188970-21-0
- Cilengitide
Catalog No.:BCC3942
CAS No.:188968-51-6
- L 760735
Catalog No.:BCC7840
CAS No.:188923-01-5
- Junipediol B 8-O-glucoside
Catalog No.:BCN4022
CAS No.:188894-19-1
- Methyl tanshinonate
Catalog No.:BCN2553
CAS No.:18887-19-9
- Hydroxytanshinone IIA
Catalog No.:BCN2497
CAS No.:18887-18-8
- DMA
Catalog No.:BCC1532
CAS No.:188860-26-6
- HX 630
Catalog No.:BCC6083
CAS No.:188844-52-2
- Hulupinic acid
Catalog No.:BCN8019
CAS No.:1891-42-5
- Salmefamol
Catalog No.:BCC1919
CAS No.:18910-65-1
- Bruceantinoside C
Catalog No.:BCN1166
CAS No.:112899-35-1
- Fas C- Terminal Tripeptide
Catalog No.:BCC1019
CAS No.:189109-90-8
- 3'-O-Methylmurraol
Catalog No.:BCN7471
CAS No.:1891097-17-8
- Naringin dihydrochalcone
Catalog No.:BCN2579
CAS No.:18916-17-1
- Tegaserod maleate
Catalog No.:BCC7955
CAS No.:189188-57-6
- Ro 48-8071 fumarate
Catalog No.:BCC5546
CAS No.:189197-69-1
- Helioxanthin
Catalog No.:BCC5413
CAS No.:18920-47-3
- KU14R
Catalog No.:BCC1685
CAS No.:189224-48-4
- Cleroindicin C
Catalog No.:BCN1167
CAS No.:189264-44-6
- Cleroindicin D
Catalog No.:BCN1168
CAS No.:189264-45-7
Strong Anti-tumorous Potential of Nardostachys jatamansi Rhizome Extract on Glioblastoma and In Silico Analysis of its Molecular Drug Targets.[Pubmed:27774879]
Curr Cancer Drug Targets. 2017;17(1):74-88.
BACKGROUND: Glioblastoma has been reckoned as the prime cause of death due to brain tumours, being the most invasive and lethal. Available treatment options, i.e. surgery, radiotherapy, chemotherapy and targeted therapies are not effective in improving prognosis, so an alternate therapy is insistent. Plant based drugs are efficient due to their synergistic action, multi-targeted approach and least side effects. METHODS: The anti-tumorous potential of Nardostachys jatamansi rhizome extract (NJRE) on U87 MG cell line was evaluated through various in vitro and in silico bio-analytical tools. RESULTS: NJRE had a strong anti-proliferative effect on U87 MG cells, Its IC50 was 33.73+/-3.5, 30.59+/-3.4 and 28.39+/-2.9 mug/mL, respectively after 24, 48 and 72 h. NJRE at 30 mug/mL induced DNA fragmentation, indicating apoptosis, early apoptosis began in the cells at 20 mug/mL, whereas higher doses exhibited late apoptosis as revealed by dual fluorescence staining. NJRE at 60 and 80 mug /mL caused a G0/G1 arrest and at 20 and 40 mug/mL showed excessive nucleation and mitotic catastrophe in the cells. Immuno-blotting validated the apoptotic mode of cell death through intrinsic pathway. NJRE was harmless to normal cells. In silico docking of NJRE marker compounds: Oroselol, jatamansinol, nardostachysin, jatamansinone and nardosinone have revealed their synergistic and multi-targeted interactions with Vestigial endothelial growth factor receptor 2 (VEGFR2), Cyclin dependent kinase 2 (CDK2), B-cell lymphoma 2 (BCL2) and Epidermal growth factor receptor (EGFR). CONCLUSION: A strong dose specific and time dependent anti-tumorous potential of NJRE on U87 MG cells was seen. The extract can be used for the development of safe and multi-targeted therapy to manage glioblastoma, which has not been reported earlier.
Biotransformation of columbianadin by rat hepatic microsomes and inhibition of biotransformation products on NO production in RAW 264.7 cells in vitro.[Pubmed:22784551]
Phytochemistry. 2012 Sep;81:109-16.
Columbianadin (CBN, 1), 1-[(8S)-8,9-dihydro-2-oxo-2H-furo[2,3-h]-1-benzopyran-8-yl]-1-methylethyl-[(2Z)-2 -methyl-2-butenoic acid]ester is a coumarin-type compound and one of the main bioactive constituents of the underground part of Angelica pubescens Maxim. f. biserrata Shan et Yuan. Although numerous investigations have been undertaken to study the biological activities of CBN, such as analgesic, anti-inflammatory, calcium-channel blocking, and platelet aggregation inhibiting functions, little attention has been paid to its metabolism and/or biotransformation. Biotransformation of CBN by rat liver microsomes in vitro was studied, and thirteen biotransformation products including eight hitherto unknown compounds [columbianadiratimetins A-H (3-10)] and five known compounds [columbianadin oxide (2), (+)-2,3-dihydro-4-hydroxy-2-(1-hydroxy-1-methylethyl)-5-benzofurancarboxaldehyde (11), Oroselol (12), columbianetin (13), and vaginol (14)] were produced by liver microsomes from rats pre-treated with sodium phenobarbital. The structures of these compounds were elucidated on the basis of extensive spectroscopic analyses which included IR, UV, EIMS, HRESIMS, 1D NMR and 2D NMR, respectively. The inhibition of CBN and its main biotransformation products on nitric oxide production induced by lipopolysaccharide was assayed in RAW 264.7 cells at concentrations ranging from 10 to 200 muM to evaluate the biological significance of biotransformation.